Clinical trials
Endocrine System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Active, not recruiting | 7 |
| Recruiting | 4 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| AstraZeneca | 4 |
| Ascendis Pharma Endocrinology Division A/S | 3 |
| CRISPR Therapeutics AG | 2 |
| McGill University | 2 |
| Pfizer | 2 |
| University of Calgary | 2 |
| Akcea Therapeutics | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Anelixis Therapeutics, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 33 |
| Metabolic Diseases | 19 |
| Glucose Metabolism Disorders | 16 |
| Diabetes Mellitus | 13 |
| Diabetes Mellitus, Type 2 | 11 |
| Autoimmune Diseases | 8 |
| Diabetes Mellitus, Type 1 | 8 |
| Immune System Diseases | 6 |
| Endocrine Gland Neoplasms | 5 |
| Neoplasms | 5 |
Trials
Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.